Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
NCT06526078 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2026-04-20
Summary
In a sample of patients already receiving ketamine (or esketamine) treatment as part of their clinical care, this project seeks to test whether we can enhance and/or extend (es)ketamine's rapid effects by introducing helpful information delivered by a computer-based cognitive training protocol. This work could ultimately lead to the ability to treat depression more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Conditions
Interventions
- BEHAVIORAL
-
Cognitive Training
Sessions of cognitive training exercises (15-20min each) self-administered via a web app
- BEHAVIORAL
-
Sham Training
Sessions of sham training exercises (15-20min each) self-administered via a web app
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
University of Pittsburgh
lead OTHER
Principal Investigators
-
Rebecca B Price, PhD · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-12
- Primary Completion
- 2029-05-31
- Completion
- 2029-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of Ketamine in Patients With Treatment-resistant Depression
NCT01627782 ·Status: COMPLETED ·Phase: PHASE2
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712 ·Status: UNKNOWN ·Phase: PHASE4
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT05991232 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Ketamine + Mindfulness for Depression
NCT05168735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neural Circuit Effects of Ketamine in Depression
NCT06213324 ·Status: RECRUITING ·Phase: PHASE4
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
NCT06419439 ·Status: RECRUITING ·Phase: PHASE2
-
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
NCT03973268 ·Status: RECRUITING ·Phase: PHASE1
-
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
NCT06480201 ·Status: SUSPENDED ·Phase: PHASE1
-
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
NCT05327699 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
NCT06069843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
NCT06788249 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Apimostinel + Automated Neurocognitive Training for Depression
NCT06400121 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
NCT06821087 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
NCT04239963 ·Status: COMPLETED
-
Ketamine Treatment Effects on Synaptic Plasticity in Depression
NCT04091971 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine for Depression: An MRI Study
NCT02544607 ·Status: COMPLETED ·Phase: PHASE4
-
A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
NCT04226963 ·Status: COMPLETED
-
Ketamine Treatment Plans for Chronic Conditions
NCT06038409 ·Status: RECRUITING
-
Nebulized Ketamine for the Treatment of Major Depressive Disorder
NCT06752759 ·Status: RECRUITING ·Phase: PHASE3
-
Ketamine for Treatment Resistant Late-Life Depression
NCT02556606 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
NCT03742557 ·Status: UNKNOWN ·Phase: PHASE3
-
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
NCT04234776 ·Status: UNKNOWN ·Phase: PHASE4
-
Antidepressant Effects of NR2B in Major Depression
NCT00472576 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Frequency Treatment for Major Depressive Disorder
NCT00646087 ·Status: WITHDRAWN ·Phase: PHASE4